Telomerase activity: A biomarker of cell proliferation, not malignant transformation

Cassandra D. Belair1, Thomas R. Yeager2, Patricia López2, Catherine A. Reznikoff2
1Department of Human Oncology, Environmental Toxicology Center, Program in Cell and Molecular Biology, and Comprehensive Cancer Center, University of Wisconsin Medical School, Madison, WI 53792
2Department of Human Oncology, Environmental Toxicology Center, Program in Cell and Molecular Biology, and Comprehensive Cancer Center, University of Wisconsin Medical School, Madison, Wisconsin

Tóm tắt

Telomerase activity is readily detected in most cancer biopsies, but not in premalignant lesions or in normal tissue samples with a few exceptions that include germ cells and hemopoietic stem cells. Telomerase activity may, therefore, be a useful biomarker for diagnosis of malignancies and a target for inactivation in chemotherapy or gene therapy. These observations have led to the hypothesis that activation of telomerase may be an important step in tumorigenesis. To test this hypothesis, we studied telomerase activity in isogeneic samples of uncultured and cultured specimens of normal human uroepithelial cells (HUCs) and in uncultured and cultured biopsies of superficial and myoinvasive transitional cell carcinoma (TCC) of the bladder. Our results demonstrated that four of four TCC biopsies, representing both superficial and myoinvasive TCCs, were positive for telomerase activity, but all samples of uncultured HUC were telomerase negative. However, when the same normal HUC samples were established as proliferating culturesin vitro, telomerase activity was readily detected but usually at lower levels than in TCCs. Consistent with the above observation of the telomerase activity in HUCs, telomeres did not shorten during the HUCin vitrolifespan. Demonstration of telomerase in proliferating human epithelial cellsin vitrowas not restricted to HUCs, because it was also present in prostate and mammary cell cultures. Notably, telomerase activity was relatively low or undetectable in nonproliferating HUC cultures. These data do not support a model in which telomerase is inactive in normal cells and activated during tumorigenic transformation. Rather, these data support a model in which the detection of telomerase in TCC biopsies, but not uncultured HUC samples, reflects differences in proliferation between tumor and normal cellsin vivo.

Từ khóa


Tài liệu tham khảo

J G Gall Telomeres, eds E H Blackburn, C W Greider (Cold Spring Harbor Lab. Press, Plainview, NY), pp. 1–10 (1995).

10.1126/science.275.5305.1478

C W Greider Telomeres, eds E H Blackburn, C W Greider (Cold Spring Harbor Lab. Press, Plainview, NY), pp. 35–68 (1995).

10.1126/science.7605428

S Kannan, H Tahara, H Yokozaki, B Mathew, K R Nalinakumari, M K Nair, E Tahara Cancer Epidem Biomarkers Prevent 6, 413–420 (1997).

K Hiyama, S Ishioka, Y Shirotani, K Inai, E Hiyama, I Murakami, T Isobe, T Inamizu, M Yamakido Oncogene 10, 937–944 (1995).

H-J Sommerfield, A K Meeker, M A Piatyszek, G S Bova, J W Shay, D S Coffey Cancer Res 56, 218–222 (1996).

H Tahara, T Nakanishi, M Kitamoto, R Nakashio, J W Shay, E Tahara, G Kajiyama, T Ide Cancer Res 55, 2734–2736 (1995).

10.1093/jnci/88.2.116

10.1038/nm0395-249

H Tahara, H Kumiyasu, H Yokozaki, W Yasui, J W Shay, T Ide, E Tahara Clin Cancer Res 1, 1245–1251 (1995).

10.1093/ajcp/107.5.555

Y Lin, H Miyamoto, K Fujinami, H Uemura, M Hosaka, Y Iwasaki, Y Kubota Clin Cancer Res 2, 929–932 (1996).

10.1093/jnci/89.10.724

10.1002/j.1460-2075.1992.tb05245.x

10.1128/mcb.14.2.961-969.1994

10.1002/j.1460-2075.1995.tb00098.x

10.1073/pnas.91.8.2882

10.1038/scientificamerican0296-92

Hiyama K. Hirai Y. Kyoizumi S. Aklyama M. Hiyama E. Piatyszek M. A. Shay J. W. Ishioka S. & Yamakido M. (1995) J. Immunol. 3711–3715.

10.1091/mbc.7.9.1443

R D M Steenbergen, J M M Walboomers, C J L M Meijer, E M H van der Raaj-Helmer, J N Parker, l T Chow, T R Broker, P J F Snijders Oncogene 13, 1249–1257 (1996).

10.1111/j.1349-7006.1995.tb02998.x

10.1126/science.7701337

S Yasumoto, C Kumimura, K Kikuchi, H Tahara, H Ohji, H Yamamoto, T Ide, T Utakoji Oncogene 13, 433–439 (1996).

10.1073/pnas.93.13.6476

S Kyo, M Takakura, T Kohama, M Inoue Cancer Res 57, 610–614 (1997).

10.1016/S0092-8674(00)81358-6

10.1002/jcp.1041310302

10.1101/gad.8.18.2227

10.1073/pnas.92.20.9363

10.1007/BF00981880

10.1016/0092-8674(89)90035-4

F M Ausubel, R Brent, R E Kingston, D D Moore, J G Seidman, J A Smith, K Struhl Preparation of Genomic DNA from Mammalian Tissues, ed V B Chanda (Wiley, New York) 1 (1997).

10.1016/S1357-4310(95)93872-9

10.1128/MCB.16.6.2932

N J Whitaker, T M Bryan, P Bonnefin, A C-M Chang, E A Musgrove, A W Braithwaite, R R Reddel Oncogene 11, 971–976 (1995).

C B Harley J NIH Res 7, 64–68 (1995).

E Hiyama, T Kodama, K Shinbara, T Iwao, M Itoh, K Hiyama, J W Shay, Y Matsuura, T Yokoyama Cancer Res 57, 326–331 (1997).

10.1126/science.7521969

10.1056/NEJM199504063321412

10.1073/pnas.89.21.10114

10.1038/345458a0

10.1002/j.1460-2075.1994.tb06822.x

P E Slagboom, S Droog, D I Boomsma Am J Hum Genet 55, 876–882 (1994).

10.1038/376403a0

V A Zakian Telomeres, eds E H Blackburn, C W Greider (Cold Spring Harbor Lab. Press, Plainview, NY), pp. 107–137 (1995).

10.1002/gcc.2870060308

T de Lange Telomeres, eds E H Blackburn, C W Greider (Cold Spring Harbor Lab. Press, Plainview, NY), pp. 265–293 (1995).